Global Helium-free Magnetocardiograph Market Growth 2026-2032
Description
The global Helium-free Magnetocardiograph market size is predicted to grow from US$ 17.72 million in 2025 to US$ 28.87 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.
Liquid helium free magnetocardiography (non superconducting magnetocardiography) is a high-end diagnostic device based on room temperature magnetic sensing technology for non-invasive detection of weak magnetic fields in the heart. It usually uses an optical pump magnetometer or other high-sensitivity room temperature magnetic sensing solutions. Compared with superconducting systems, it does not require low-temperature cooling and complex shielding, and has more friendly installation and operation conditions, making it more suitable for clinical promotion and application. Based on existing data, the global sales volume is estimated to be around 23 units in 2025, with an average unit price of approximately $787000. Due to the complexity of system integration and the supply of core sensors, the overall industry capacity utilization rate is approximately 68%. Upstream enterprises are mainly distributed in the fields of high-sensitivity room temperature magnetic sensors, precision optical devices, low-noise electronic and signal processing chips, magnetic shielding materials, etc., while downstream enterprises are concentrated in the fields of medical equipment manufacturing, clinical system integration, and hospital delivery services, with an overall gross profit margin of about 35% to 48%. In the product cost structure, core magnetic sensors and optical systems account for about 40% of the total cost, electronic and algorithm hardware account for about 20%, system integration and assembly account for about 20%, research and development testing accounts for about 10%, and sales and after-sales service account for about 10%. According to parameters and configurations, non superconducting magnetocardiography can be classified into fixed and semi mobile systems, as well as different configuration versions for scientific research and clinical screening. In terms of demand, the downstream demand list includes early screening for arrhythmia and cardiomyopathy in large hospitals, monitoring of cardiac function in newborns and children, evaluation of cardiac inflammation and drug cardiac safety, construction of regional cardiovascular diagnosis and treatment centers, and research on biomagnetism in universities and research institutions; The downstream customer list mainly includes cardiology departments of tertiary hospitals, specialized cardiac hospitals, medical research institutes, and high-end physical examination and functional medicine centers. In terms of business opportunities, policy drivers are reflected in the continuous strengthening of early diagnosis and screening of cardiovascular diseases and support for the localization of high-end medical equipment. Technological innovation drivers are focused on improving the sensitivity of room temperature magnetic sensing, the maturity of multi-channel array algorithms and artificial intelligence assisted interpretation, and changes in consumer demands are reflected in the significant increase in clinical attention to non-invasive testing, controllable operation and maintenance costs, and higher cost-effectiveness solutions. These factors together promote non superconducting magnetocardiography to become the most important incremental direction in the magnetocardiography market in the coming years.
The absence of liquid helium magnetocardiography represents an important direction for the evolution of the magnetocardiography industry towards scalable clinical applications. Its core value lies in completely eliminating the dependence on liquid helium, significantly reducing operational complexity and long-term usage costs, and enabling magnetocardiography to move from a few research centers to more clinical scenarios. The current market is still in the stage of introduction and verification, with installations mainly concentrated in technologically advanced cardiac specialty hospitals and research institutions. However, with the improvement of room temperature magnetic sensor sensitivity, mature low-noise algorithms, and advances in system level magnetic shielding and compensation technology, the liquid helium free solution is rapidly approaching traditional superconducting systems in terms of clinical availability and stability. From the demand side, hospitals place significantly higher emphasis on equipment reliability, continuous operation capability, and full lifecycle cost than on extreme sensitivity, making liquid helium free magnetocardiography more attractive in medical institutions with budget constraints but pursuing advanced diagnostic capabilities. In the medium to long term, the support of policies for the localization and green low-carbon operation of high-end medical equipment, the evolution of technological routes towards standardization and modularization, and the continuous growth of patients' demand for non-invasive and precise cardiac testing will jointly promote the steady increase in the market share of liquid helium free magnetocardiography, becoming a key breakthrough for the magnetocardiography industry to move from a high barrier niche market to a sustainable and high-volume market.
LP Information, Inc. (LPI) ' newest research report, the “Helium-free Magnetocardiograph Industry Forecast” looks at past sales and reviews total world Helium-free Magnetocardiograph sales in 2025, providing a comprehensive analysis by region and market sector of projected Helium-free Magnetocardiograph sales for 2026 through 2032. With Helium-free Magnetocardiograph sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helium-free Magnetocardiograph industry.
This Insight Report provides a comprehensive analysis of the global Helium-free Magnetocardiograph landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Helium-free Magnetocardiograph portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helium-free Magnetocardiograph market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helium-free Magnetocardiograph and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helium-free Magnetocardiograph.
This report presents a comprehensive overview, market shares, and growth opportunities of Helium-free Magnetocardiograph market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Coil Magnetocardiography Magnetocardiography System
Magnetic Reluctance Magnetocardiography System
Atomic Magnetometer Magnetocardiography System
Segmentation by Open or Closed:
Fully Enclosed Type
Semi-Open Type
Open-Ended Type
Segmentation by Channels:
32 Channel Type
64 Channel Type
96 Channel Type
Other
Segmentation by Application:
Medical
Research and Education
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Beijing X-Magtech Technologies
Genetesis
Hangzhou Nuochi Life Science
Hangzhou Chinmag Technology
SandboxAQ
Hangzhou Lingci Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Helium-free Magnetocardiograph market?
What factors are driving Helium-free Magnetocardiograph market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Helium-free Magnetocardiograph market opportunities vary by end market size?
How does Helium-free Magnetocardiograph break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Liquid helium free magnetocardiography (non superconducting magnetocardiography) is a high-end diagnostic device based on room temperature magnetic sensing technology for non-invasive detection of weak magnetic fields in the heart. It usually uses an optical pump magnetometer or other high-sensitivity room temperature magnetic sensing solutions. Compared with superconducting systems, it does not require low-temperature cooling and complex shielding, and has more friendly installation and operation conditions, making it more suitable for clinical promotion and application. Based on existing data, the global sales volume is estimated to be around 23 units in 2025, with an average unit price of approximately $787000. Due to the complexity of system integration and the supply of core sensors, the overall industry capacity utilization rate is approximately 68%. Upstream enterprises are mainly distributed in the fields of high-sensitivity room temperature magnetic sensors, precision optical devices, low-noise electronic and signal processing chips, magnetic shielding materials, etc., while downstream enterprises are concentrated in the fields of medical equipment manufacturing, clinical system integration, and hospital delivery services, with an overall gross profit margin of about 35% to 48%. In the product cost structure, core magnetic sensors and optical systems account for about 40% of the total cost, electronic and algorithm hardware account for about 20%, system integration and assembly account for about 20%, research and development testing accounts for about 10%, and sales and after-sales service account for about 10%. According to parameters and configurations, non superconducting magnetocardiography can be classified into fixed and semi mobile systems, as well as different configuration versions for scientific research and clinical screening. In terms of demand, the downstream demand list includes early screening for arrhythmia and cardiomyopathy in large hospitals, monitoring of cardiac function in newborns and children, evaluation of cardiac inflammation and drug cardiac safety, construction of regional cardiovascular diagnosis and treatment centers, and research on biomagnetism in universities and research institutions; The downstream customer list mainly includes cardiology departments of tertiary hospitals, specialized cardiac hospitals, medical research institutes, and high-end physical examination and functional medicine centers. In terms of business opportunities, policy drivers are reflected in the continuous strengthening of early diagnosis and screening of cardiovascular diseases and support for the localization of high-end medical equipment. Technological innovation drivers are focused on improving the sensitivity of room temperature magnetic sensing, the maturity of multi-channel array algorithms and artificial intelligence assisted interpretation, and changes in consumer demands are reflected in the significant increase in clinical attention to non-invasive testing, controllable operation and maintenance costs, and higher cost-effectiveness solutions. These factors together promote non superconducting magnetocardiography to become the most important incremental direction in the magnetocardiography market in the coming years.
The absence of liquid helium magnetocardiography represents an important direction for the evolution of the magnetocardiography industry towards scalable clinical applications. Its core value lies in completely eliminating the dependence on liquid helium, significantly reducing operational complexity and long-term usage costs, and enabling magnetocardiography to move from a few research centers to more clinical scenarios. The current market is still in the stage of introduction and verification, with installations mainly concentrated in technologically advanced cardiac specialty hospitals and research institutions. However, with the improvement of room temperature magnetic sensor sensitivity, mature low-noise algorithms, and advances in system level magnetic shielding and compensation technology, the liquid helium free solution is rapidly approaching traditional superconducting systems in terms of clinical availability and stability. From the demand side, hospitals place significantly higher emphasis on equipment reliability, continuous operation capability, and full lifecycle cost than on extreme sensitivity, making liquid helium free magnetocardiography more attractive in medical institutions with budget constraints but pursuing advanced diagnostic capabilities. In the medium to long term, the support of policies for the localization and green low-carbon operation of high-end medical equipment, the evolution of technological routes towards standardization and modularization, and the continuous growth of patients' demand for non-invasive and precise cardiac testing will jointly promote the steady increase in the market share of liquid helium free magnetocardiography, becoming a key breakthrough for the magnetocardiography industry to move from a high barrier niche market to a sustainable and high-volume market.
LP Information, Inc. (LPI) ' newest research report, the “Helium-free Magnetocardiograph Industry Forecast” looks at past sales and reviews total world Helium-free Magnetocardiograph sales in 2025, providing a comprehensive analysis by region and market sector of projected Helium-free Magnetocardiograph sales for 2026 through 2032. With Helium-free Magnetocardiograph sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helium-free Magnetocardiograph industry.
This Insight Report provides a comprehensive analysis of the global Helium-free Magnetocardiograph landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Helium-free Magnetocardiograph portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Helium-free Magnetocardiograph market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helium-free Magnetocardiograph and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helium-free Magnetocardiograph.
This report presents a comprehensive overview, market shares, and growth opportunities of Helium-free Magnetocardiograph market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Coil Magnetocardiography Magnetocardiography System
Magnetic Reluctance Magnetocardiography System
Atomic Magnetometer Magnetocardiography System
Segmentation by Open or Closed:
Fully Enclosed Type
Semi-Open Type
Open-Ended Type
Segmentation by Channels:
32 Channel Type
64 Channel Type
96 Channel Type
Other
Segmentation by Application:
Medical
Research and Education
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Beijing X-Magtech Technologies
Genetesis
Hangzhou Nuochi Life Science
Hangzhou Chinmag Technology
SandboxAQ
Hangzhou Lingci Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Helium-free Magnetocardiograph market?
What factors are driving Helium-free Magnetocardiograph market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Helium-free Magnetocardiograph market opportunities vary by end market size?
How does Helium-free Magnetocardiograph break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
99 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Helium-free Magnetocardiograph by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Helium-free Magnetocardiograph by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
